MDT Maintained by BTIG -- Price Target Lowered to $99.00

gurufocus.com · 2026-10-12

Medtronic (MDT) Analyst Rating Update - October 12, 2026 On October 12, 2026, BTIG maintained a 'Buy' rating on Medtronic (MDT), adjusting the price target f

TickrTrends take: BTIG's reduction of MDT's price target to $99 occurs within a valuation context where TickrTrends currently assesses the stock as undervalued relative to its fundamentals. This analyst adjustment provides a data point for investors tracking whether consensus expectations are converging with or diverging from the current market price. For valuation-focused readers, the relevant consideration is whether this revised target reflects a reassessment of the company's Healthcare sector positioning or represents a technical adjustment that alters the gap between current trading levels and analyst expectations.

Read the full story at gurufocus.com →